<<

MONDAY November 6, 2017 5:30 PM – 8:30 PM

Barry D. Brown Health Education Center (HEC) 106 Carnie Boulevard Voorhees NJ, 08043

Penn - Virtua Program PRESENTS RECENT ADVANCES IN FOR THE PRIMARY CARE - NEW JERSEY A CME-CERTIFIED COURSE

REGISTER ONLINE AT PENNMEDICINE.ORG/CME/PCP/VIRTUA

CONTACT For additional information, contact Barbara Lopez 215.614.1954 | [email protected]

C A N C E R P R O G R A M DIRECTIONS Virtua.org/locations/barry-brown-health-education-center RECENT ADVANCES IN ONCOLOGY FOR THE - NEW JERSEY 5:30 to 8:30 PM COCKTAILS, DINNER

The purpose of this activity is to provide primary care and other primary providers with AND PROGRAM education about cancer screening, risk evaluation, diagnostic and treatment advances and survivorship care.

TARGET AUDIENCE AGENDA This activity has been designed for primary care physicians including: general medicine, , family practice, 5:30 PM Registration, Cocktails and Hors d’oeuvres gynecologist, primary care practice nurses, and other health- care professionals involved in the primary care of patients. 6:00 PM Welcome/Introductions Seth H. Berk, MD and Samuel Weiner, MD LEARNING OBJECTIVES 6:10 PM Update on Immunotherapy/Targeted and Upon completion of this course, participants should be able to: Managing Toxicities – Practice Implications for the PCP • Identify new advances in cancer treatment including: Lynn M. Schuchter, MD | Oncology immunotherapy, precision , and proton • Describe the PCP role in lung cancer screening 6:25 PM Advances in Precision Surgery: Minimally Invasive Brain Surgery and Penn Medicine’s • Explain the latest advances in surgical and systemic TM therapies for lung cancer TumorGlow Technology John Y.K. Lee, MD, MSCE | • Describe the latest evidence for gynecologic malignancies screening and HPV vaccination 6:40 PM Advances in for the Primary Clinician: Update on Stereotactic Radiosurgery, High Dose Brachytherapy and Proton Therapy SPEAKERS David D Wilson, MD, MSCR | Radiation Oncology Patrick J. Connolly, MD | Neurosurgery Benjamin Goldsmith, MD | Radiation Oncology COURSE DIRECTORS 7:15 PM Gynecologic Malignancies – Update on Screening Seth H. Berk, MD Medical Director | Penn–Virtua Cancer Program and HPV Vaccine Randolph Deger, MD | Gynecologic Oncology Richard H. Greenberg, MD Penn Medicine Clinician, Hematology/Oncology Nawar A. Latif MD, MPH, MSCE | Gynecologic Oncology Lynn M. Schuchter, MD 7:35 PM Lung Cancer Advances: Screening and Precision Medicine C. Willard Robinson Professor of Hematology/Oncology, Matthew Puc, MD | Division Chief, Hematology/Oncology | Perelman School Richard Greenberg, MD | Hematology/Oncology of Medicine at the University of Pennsylvania 8:05 PM Panel Discussion/Questions and Answers Samuel Weiner, MD Panel Moderators: Seth Berk, MD and Samuel Weiner, MD Virtua Clinician, Panel: All speakers above 8:30 PM Meeting Adjourns PENN MEDICINE/VIRTUA PHYSICIANS Benjamin Goldsmith, MD Clinician, Radiation Oncology | Penn Medicine Please note that most conference material will be available online. Please bring your electronic device to view presentations in real time. Patrick Connolly, MD Clinician, Neurosurgery | Penn Medicine at Virtua Randolph Deger, MD REGISTER ONLINE AT Clinician, Gynecologic Oncology | Virtua Nawar A. Latif MD, MPH, MSCE PennMedicine.org/CME/PCP/Virtua Clinician, Gynecologic Oncology | Penn Medicine at Virtua John YK Lee, MD, MSCE ACCREDITATION AND DESIGNATION OF CREDIT Associate Professor of Neurosurgery | Perelman School of The Perelman School of Medicine at the University of Pennsylvania is accredited by the Medicine at the University of Pennsylvania Accreditation Council for Continuing (ACCME) to provide continuing medical Matthew Puc, MD education for physicians. Clinician, Cardiothoracic Surgery | Virtua The Perelman School of Medicine at the University of Pennsylvania designates this live activity David D Wilson, MD, MSCR for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit Clinician, Radiation Oncology | Penn Medicine at Virtua commensurate with the extent of their participation in the activity.